日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Vagus nerve-mediated neuroimmune modulation for rheumatoid arthritis: a pivotal randomized controlled trial

迷走神经介导的神经免疫调节治疗类风湿性关节炎：一项关键性随机对照试验

期刊:Nature Medicine
影响因子:50
doi:10.1038/s41591-025-04114-7
Tesser, John R P; Crowley, Angela R; Box, Emily Jane; June, Joshua P; Wickersham, Pendleton Brewster; Valenzuela, Guillermo J; Gaylis, Norman B; Lam, Gordon K W; Pacheco, Leroy A; Ridley, David J; Pinto-Patarroyo, Gineth Paola; Novack, Stuart N; Churchill, Melvin A; Kohler, Minna; Lee, Eric C; Pando, Jose A; Parris, Glenn R; Peterson, Jeff R; Shah, Tina; Singhal, Atul K; Vuong, Victoria; Levine, Yaakov A; Evangelista, Melissa L; Derosier, Amy A; Curtis, Jeffrey R; Richardson, R Mark; Chernoff, David
关节炎
免疫/内分泌
发表日期：2026
文献求助 收藏

Correction to: Efficacy, Safety, and Immunogenicity of SDZ-ADL, an Adalimumab Biosimilar, in Biologic-Naïve and Switched Patients with Immune-Mediated Inflammatory Diseases: A Literature Review

更正：SDZ-ADL（一种阿达木单抗生物类似药）在未接受过生物制剂治疗和转换治疗的免疫介导炎症性疾病患者中的疗效、安全性和免疫原性：文献综述

期刊:Advances in Therapy
影响因子:4
doi:10.1007/s12325-025-03181-z
Wiland, Piotr; Both, Charlotte; Gaylis, Norman B; Cohen, Russell D; Halfvarson, Jonas; Lemke, Lena; von Richter, Oliver; Blauvelt, Andrew
炎症/感染
炎症
免疫/内分泌
发表日期：2025
文献求助 收藏

Efficacy, Safety, and Immunogenicity of SDZ-ADL, an Adalimumab Biosimilar, in Biologic-Naïve and Switched Patients with Immune-Mediated Inflammatory Diseases: A Literature Review

SDZ-ADL（一种阿达木单抗生物类似药）在既往未接受过生物制剂治疗和转换治疗的免疫介导炎症性疾病患者中的疗效、安全性和免疫原性：文献综述

期刊:Advances in Therapy
影响因子:4
doi:10.1007/s12325-024-03098-z
Wiland, Piotr; Both, Charlotte; Gaylis, Norman B; Cohen, Russell D; Halfvarson, Jonas; Lemke, Lena; von Richter, Oliver; Blauvelt, Andrew
炎症/感染
炎症
免疫/内分泌
发表日期：2025
文献求助 收藏

Neuroimmune Modulation for Drug-Refractory Rheumatoid Arthritis: Long-Term Safety and Efficacy in Patients Enrolled in a Pilot Vagus Nerve Stimulation Study

神经免疫调节治疗药物难治性类风湿性关节炎：一项迷走神经刺激试点研究的长期安全性和有效性

期刊:Rheumatology and Therapy
影响因子:2.9
doi:10.1007/s40744-025-00798-y
Gaylis, Norman B; Sikes, David; Kivitz, Alan; Horowitz, Diane Lewis; Evangelista, Melissa; Levine, Yaakov A; Chernoff, David
关节炎
免疫/内分泌
发表日期：2025
文献求助 收藏

'Totality of Evidence' Approach in the Development of GP2017, an Approved Adalimumab Biosimilar

在已获批准的阿达木单抗生物类似药GP2017的研发过程中采用“证据总体性”方法

期刊:Advances in Therapy
影响因子:4
doi:10.1007/s12325-024-02809-w
Gaylis, Norman; Both, Charlotte; Lemke, Lena; von Richter, Oliver; Yamauchi, Paul
发表日期：2024
文献求助 收藏

Time Trends and Variation in the Use of Active Surveillance for Management of Low-risk Prostate Cancer in the US

美国低风险前列腺癌主动监测管理的时间趋势和变化

期刊:Jama Network Open
影响因子:9.7
doi:10.1001/jamanetworkopen.2023.1439
Cooperberg, Matthew R; Meeks, William; Fang, Raymond; Gaylis, Franklin D; Catalona, William J; Makarov, Danil V
肿瘤
前列腺癌
肿瘤免疫
发表日期：2023
文献求助 收藏

The results of a unique dietary supplement (nutraceutical formulation) used to treat the symptoms of long-haul COVID

一种用于治疗新冠长期症状的独特膳食补充剂（营养保健品配方）的研究结果

期刊:Frontiers in Nutrition
影响因子:5.1
doi:10.3389/fnut.2022.1034169
Gaylis, Norman B; Kreychman, Ida; Sagliani, Joanne; Mograbi, Josef; Gabet, Yankel
微生物学
新冠
发表日期：2022
文献求助 收藏

Considering Immuno-autonomics in Stratifying Successful Treatment of Rheumatoid Arthritis with Tumor Necrosis Factor Inhibition: Comment on Cohen et al. Rheumatol Ther 2021 June 19

考虑免疫自主系统因素对肿瘤坏死因子抑制剂治疗类风湿性关节炎的成功进行分层：对 Cohen 等人发表于 Rheumatol Ther 2021 年 6 月 19 日的文章的评论

期刊:Rheumatology and Therapy
影响因子:2.9
doi:10.1007/s40744-021-00386-w
Holman, Andrew J; Keystone, Edward; Choy, Ernest; Furst, Daniel; Taylor, Peter; Gaylis, Norman
关节炎
肿瘤
肿瘤免疫
免疫/内分泌
发表日期：2022
文献求助 收藏

Treatment with SDZ-ADL, an Adalimumab Biosimilar, in Patients with Rheumatoid Arthritis, Psoriasis, or Psoriatic Arthritis: Results of Patient-Reported Outcome Measures from Two Phase III Studies (ADMYRA and ADACCESS)

使用 SDZ-ADL（阿达木单抗生物类似药）治疗类风湿性关节炎、银屑病或银屑病关节炎患者：两项 III 期研究（ADMYRA 和 ADACCESS）的患者报告结局指标结果

期刊:BioDrugs
影响因子:6.9
doi:10.1007/s40259-021-00470-1
Blauvelt, Andrew; Leonardi, Craig L; Gaylis, Norman; Jauch-Lembach, Julia; Balfour, Alison; Lemke, Lena; Hachaichi, Sohaib; Brueckmann, Ines; Festini, Teodora; Wiland, Piotr
关节炎
银屑病
ADA
发表日期：2021
文献求助 收藏

Switching to Biosimilar SDZ-ADL in Patients with Moderate-to-Severe Active Rheumatoid Arthritis: 48-Week Efficacy, Safety and Immunogenicity Results From the Phase III, Randomized, Double-Blind ADMYRA Study

在患有中重度活动性类风湿关节炎的患者中改用生物类似药SDZ-ADL：来自III期随机双盲ADMYRA研究的48周疗效、安全性和免疫原性结果

期刊:BioDrugs
影响因子:6.9
doi:10.1007/s40259-020-00447-6
Wiland, Piotr; Jeka, Sławomir; Dokoupilová, Eva; Brandt-Jürgens, Jan; Miranda Limón, Juan Manuel; Cantalejo Moreira, Miguel; Cabello, Raul Veiga; Jauch-Lembach, Julia; Thakur, Anjali; Haliduola, Halimuniyazi; Brueckmann, Ines; Gaylis, Norman B
关节炎
免疫/内分泌
发表日期：2020
文献求助 收藏